Evidence map›Paper›PMID 41416799›Full record

ArticleAntimicrobial agents and chemotherapy2026

Isobavachalcone effectively inhibits the growth of

Ping Xie, Wenting Zhou, Jiazi Luo, Yuanyuan Dai, Shixian Yang, Shufang Li, Yanqiang Huang

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ping Xie *Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Wenting Zhou *Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Jiazi LuoGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Yuanyuan DaiDepartment of Stomatology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Shixian YangDepartment of Stomatology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.ORCID 0009-0001-4377-4562
Shufang LiDepartment of Stomatology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.ORCID 0000-0003-4679-4005
Yanqiang HuangGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.ORCID 0000-0002-0867-0178

Funding

Guangxi Science and Technology Major projects AA23073012National Natural Science Foundation of China 32060018National Natural Science Foundation of China 32360035
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsCandida albicansChalconesAdenosine TriphosphateAnimalsCandidiasisCandidiasis, OralCandidiasis, VulvovaginalFemaleFluconazoleFungal ProteinsMiceMicrobial Sensitivity TestsOxidative StressAdenosine TriphosphateAntifungal AgentsChalconesFluconazoleFungal ProteinsisobavachalconeADK1antifungal mechanismATP biosynthesisC. albicansisobavachalcone

Identifiers

PMID41416799
PMCPMC12888897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.